# Swiss HCVree Trial

> **NCT02785666** · PHASE3 · COMPLETED · sponsor: **University of Zurich** · enrollment: 150 (actual)

## Conditions studied

- Hepatitis C
- HIV

## Interventions

- **DRUG:** grazoprevir/elbasvir, ribavirin
- **BEHAVIORAL:** Behavioural Intervention

## Key facts

- **NCT ID:** NCT02785666
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2018-04
- **Final completion:** 2018-08
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2018-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02785666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02785666, "Swiss HCVree Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02785666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*